References
- WirtaDVandenburghAMWengEWhitcupSMKurstjensSBedding-fieldFC3rdLong-term safety evaluation of bimatoprost ophthalmic solution 0.03%: a pooled analysis of six double-masked, randomized, active-controlled clinical trialsClin Ophthalmol2011575976521691584
- LeeAJMcCluskeyPClinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertensionClin Ophthalmol2010474176420689791
- WhitcupSMCantorLBVanDenburghAMChenKA randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertensionBr J Ophthalmol2003871576212488264
- DoshiMEdwardDPOsmanovicSClinical course of bimatoprost-induced periocular skin changes in CaucasiansOphthalmology2006113111961196716935336
- FilippopoulosTPaulaJSTorunNHattonMPPasqualeLRGrosskreutzCLPeriorbital changes associated with topical bimatoprostOphthal Plast Reconstr Surg2008244302307
- JayaprakasamAGhazi-NouriSPeriorbital fat atrophy – an unfamiliar side effect of prostaglandin analoguesOrbit201029635735921158579
- SiraMVerityDHMalhotraRTopical bimatoprost 0.03% and iatrogenic eyelid and orbital lipodystrophyAesthet Surg J201232782282422942109
- NomaKKakizakiHBilateral upper eyelid retraction caused by topical bimatoprost therapyOphthal Plast Reconstr Surg2012282e33e35
- InoueKShiokawaMWakakuraMTomitaGDeepening of the upper eyelid sulcus caused by 5 types of prostaglandin analogsJ Glaucoma201322862663122936280
- AiharaMShiratoSSakataRIncidence of deepening of the upper eyelid sulcus after switching from latanoprost to bimatoprostJpn J Ophthalmol201155660060421953485
- PasqualeLRProstaglandin-associated periorbitopathy: a postmarketing surveillance observationGlaucoma Today20119515258 Available from: http://bmctoday.net/glaucomatoday/pdfs/gt0611_thera_pasquale.pdfAccessed November 29, 2013
- MillerCWCasimirDANtambiJMThe mechanism of inhibition of 3T3-L1 preadipocyte differentiation by prostaglandin F2alphaEndocrinology199613712564156508940395
- LepakNMSerreroGProstaglandin F2 alpha stimulates transforming growth factor-alpha expression in adipocyte precursorsEndocrinoology1995136832223229
- ReginatoMJKrakowSLBaileySTLazarMAProstaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gammaJ Biol Chem19982734185518589442016
- ChoiHYLeeJELeeJWParkHJJungJHIn vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadipocytesJ Ocul Pharmacol Ther201228214615222107041
- KikkawaDOKimJWAsian blepharoplastyInt Ophthalmol Clin19973731932049279651
- PeplinskiLSAlbiani SmithKDeepening of lid sulcus from topical bimatoprost therapyOptom Vis Sci200481857457715300114
- WoodwardJAHaggertyCJStinnettSSWilliamsZYBimatoprost 0.03% for cosmetic eyelash growth and enhancementJ Cosmet Dermatol2010929610220618554